⚠️
Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Rubella (Meruvax II)
RUB1,021 total reports
Share
1,021
Total Reports
3
Deaths
66
Hospitalizations
420
ER Visits
68
Disabilities
About Rubella (Meruvax II)
Rubella (Meruvax II) has 1,021 reports in VAERS spanning from 1990 to 2026.
Of these reports, 3 mentioned death, 66 involved hospitalization, and 420 required emergency department visits.
This vaccine is manufactured by: Merck & Co., Unknown Manufacturer, Sanofi Pasteur, Burroughs Wellcome.
This vaccine accounts for 0.1% of all 1,983,260 reports in the VAERS database.
Reporting Rate
This vaccine averages 34 reports per year over 30 years of reporting (1990–2020).
Understanding These Numbers
•Reports don't prove causation. They represent temporal associations where someone experienced an event after vaccination.
•Background rates matter. Many conditions occur naturally and may coincidentally happen after vaccination.
•Reporting varies by vaccine. Newer vaccines or those in the news may have higher reporting rates due to increased awareness.
Most Reported Symptoms
Top Reporting States
Explore Further
Related Analysis
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.